Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward P Cohen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cellsTae Sung Kim, Amla Chopra, In Sug O-Sullivan, et al.
International Journal of Cancer|December 29, 2005
Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccineAmla Chopra, Tae Sung Kim, Insug O-Sullivan, et al.
International Journal of Cancer|February 16, 2006
Treatment of squamous carcinoma in mice with a vaccine enriched for cells that induce immunity to squamous carcinoma--a new vaccination strategyAmla Chopra, Tae Sung Kim, InSug O-Sullivan, et al.
Cancer Research|April 3, 2008
Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in miceInSug O-Sullivan, Amla Chopra, Janai Carr, et al.
Cancer Gene Therapy|April 2, 2005
Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancerTerry Lichtor, Roberta P Glick, Henry Lin, et al.
Vaccine|September 17, 2008
Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing miceTae S Kim, Byeong C Lee, Eugene Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2017
Aminoacyl tRNA Synthetase--Interacting Multifunctional Protein 1 Activates NK Cells via Macrophages In Vitro and In VivoMyun Soo Kim, Ju Han Song, Edward P Cohen, et al.
Cancer Gene Therapy|April 19, 2002
Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumorsTerry Lichtor, Roberta P Glick, Katherine Tarlock, et al.
Cancer Therapy|August 16, 2006
Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in miceTerry Lichtor, Roberta P Glick, Henry Lin, et al.
Journal of Neurosurgery|April 7, 2007
Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblastsAlessandra Spagnolo, Roberta P Glick, Henry Lin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cellsTae Sung Kim, Amla Chopra, In Sug O-Sullivan, et al.
International Journal of Cancer|December 29, 2005
Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccineAmla Chopra, Tae Sung Kim, Insug O-Sullivan, et al.
International Journal of Cancer|February 16, 2006
Treatment of squamous carcinoma in mice with a vaccine enriched for cells that induce immunity to squamous carcinoma--a new vaccination strategyAmla Chopra, Tae Sung Kim, InSug O-Sullivan, et al.
Cancer Research|April 3, 2008
Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in miceInSug O-Sullivan, Amla Chopra, Janai Carr, et al.
Cancer Gene Therapy|April 2, 2005
Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancerTerry Lichtor, Roberta P Glick, Henry Lin, et al.
Vaccine|September 17, 2008
Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing miceTae S Kim, Byeong C Lee, Eugene Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2017
Aminoacyl tRNA Synthetase--Interacting Multifunctional Protein 1 Activates NK Cells via Macrophages In Vitro and In VivoMyun Soo Kim, Ju Han Song, Edward P Cohen, et al.
Cancer Gene Therapy|April 19, 2002
Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumorsTerry Lichtor, Roberta P Glick, Katherine Tarlock, et al.
Cancer Therapy|August 16, 2006
Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in miceTerry Lichtor, Roberta P Glick, Henry Lin, et al.
Journal of Neurosurgery|April 7, 2007
Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblastsAlessandra Spagnolo, Roberta P Glick, Henry Lin, et al.
Pageof 3